Companies in the biopharma sector developing innovative solutions and technologies.
Explore 915 recently funded biopharma companies with verified founder contact information and fundraising data.
ALLOX is a biotechnology company developing an experimental and artificial intelligence platform for drug discovery.
EpiDisease provides biomedical solutions, epigenetic diagnostic tools, and characterization of new epigenetic drugs.
Hexagon Bio discovers and develops new cancer therapies using microbial natural products, genomic data, and artificial intelligence.
Warp Sciences is a life sciences infrastructure company that integrates artificial intelligence and advanced robotics.
BioStack is a digital platform that provides healthcare AI training environments and curated multimodal clinical datasets.
Arctic Therapeutics is a drug discovery and development company that focuses on identifying genetic causes of major diseases.
100XBIO develops single-cell and spatial biology technologies enabling high-resolution cellular analysis for research and drug discovery.
Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.
Microbiotica develops microbiome-based medicines that use selected gut bacteria for the treatment of cancer and inflammatory bowel diseases.
SilVia Bio develops cell profiling and media additive solutions to optimize mammalian cell biomanufacturing processes.
Medical Aesthetics, Longevity, Anti-Aging, Regenerative Medicine, Wound Care, Human Collagen
HydRegen is a biotechnology company that provides sustainable solutions for chemical manufacturing.
Verastem is a biopharmaceutical company developing new medicines to improve the lives of patients with RAS/MAPK pathway-driven cancers.
Kaigene is a biotechnology company that develops antibody therapeutics through research and preclinical studies.
Soufflé Therapeutics has potent, precise, and safe medicines can be designed and developed for all diseases.
RadioNano Therapeutics is a medical technology company that develops radiation therapy solutions for the treatment of cancer patients.
Onyx is a research collective building a virtual immune system from longitudinal human immune data.
ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products.
Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.
KymaThera is an biotech startup that develops precision small-molecule drugs targeting diseases like cancer and fibrosis.
Hinalea offers intelligent hyperspectral imaging solutions combining advanced sensors with AI powered software for industrial applications
CAD Therapeutics is a biopharmaceutical company developing novel therapeutic candidates targeting post-traumatic stress disorder.
AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure.
A clinical-stage company operating Japan’s first GMP-compliant manufacturing platform for fecal microbiota transplantation (FMT) therapies.
Breye Therapeutics, a biopharmaceutical firm that provide cutting-edge oral treatments for the management of retinal vascular diseases.
The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 915 biopharma companies tracked in the VCBacked database.
Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked